NCT01860625View on ClinicalTrials.gov

A Phase I Clinical, Dose Escalation Study of the Safety, Tolerability and Pharmacokinetics of Donepezil Patch in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

December 31, 2013

Study Completion Date

February 28, 2014

Conditions
Alzheimer Disease
Interventions
DRUG

Donepezil patch

DRUG

placebo

Trial Locations (1)

138-736

ASAN Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

Icure Pharmaceutical Inc.

INDUSTRY

NCT01860625 - A Phase I Clinical, Dose Escalation Study of the Safety, Tolerability and Pharmacokinetics of Donepezil Patch in Healthy Male Subjects | Biotech Hunter | Biotech Hunter